Loading EBS charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading EBS comparable companies…
| EBSEmergent BioSolutions Inc.(opens in a new tab) | $0.35B | $0.77B | −9.6% | 55.9% | −8.6% | 0.46× | — |
|---|---|---|---|---|---|---|---|
| AXSMAxsome Therapeutics, Inc.(opens in a new tab) | $7.49B | $0.78B | +56.9% | 93.2% | −24.0% | 9.65× | — |
| PCRXPacira BioSciences, Inc.(opens in a new tab) | $1.47B | $0.75B | +5.7% | 79.2% | 2.7% | 1.97× | 104.0× |
| TGTXTG Therapeutics, Inc.(opens in a new tab) | $9.63B | $0.80B | +76.1% | 82.4% | 17.1% | 12.04× | 22.3× |
| COLLCollegium Pharmaceutical, Inc.(opens in a new tab) | $0.77B | $0.81B | +14.3% | 60.0% | 19.5% | 0.96× | 19.2× |
| Medianpeers, excl. EBS | $4.48B | $0.79B | +35.6% | 80.8% | 9.9% | 5.81× | 22.3× |